{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:54:26Z","timestamp":1788965666409,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82000210"],"award-info":[{"award-number":["82000210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Clinical Research Center for Hematological Malignancies","award":["2020Y2006"],"award-info":[{"award-number":["2020Y2006"]}]},{"name":"Sichuan science and technology department for key research and development projects","award":["2019YFS0027"],"award-info":[{"award-number":["2019YFS0027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18148-x","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:13:24Z","timestamp":1760361204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter study"],"prefix":"10.1038","volume":"15","author":[{"given":"Xufei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TianYu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caigang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"20","key":"18148_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127 (20), 2375\u20132390 (2016).","journal-title":"Blood"},{"issue":"9","key":"18148_CR2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning, M. A. & Vose, J. M. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood 129 (9), 1095\u20131102 (2017).","journal-title":"Blood"},{"issue":"25","key":"18148_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose, J., Armitage, J. & Weisenburger, D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26 (25), 4124\u20134130 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"18148_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani, R. H. et al. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project. Blood 138 (3), 213\u2013220 (2021).","journal-title":"Blood"},{"issue":"5","key":"18148_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/bjh.19089","volume":"203","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Angioimmunoblastic T-cell lymphoma: novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling. Br. J. Haematol. 203 (5), 807\u2013819 (2023).","journal-title":"Br. J. Haematol."},{"issue":"13","key":"18148_CR6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"388","author":"CJ Haug","year":"2023","unstructured":"Haug, C. J. & Drazen, J. M. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl. J. Med. 388 (13), 1201\u20131208 (2023).","journal-title":"N Engl. J. Med."},{"issue":"20","key":"18148_CR7","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo, R. C. Machine learning in medicine. Circulation 132 (20), 1920\u20131930 (2015).","journal-title":"Circulation"},{"issue":"7","key":"18148_CR8","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1016\/S2352-3026(20)30121-6","volume":"7","author":"N Radakovich","year":"2020","unstructured":"Radakovich, N., Nagy, M. & Nazha, A. Machine learning in haematological malignancies. Lancet Haematol. 7 (7), e541\u2013e550 (2020).","journal-title":"Lancet Haematol."},{"issue":"1","key":"18148_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/cancers14010188","volume":"14","author":"GM Zaccaria","year":"2021","unstructured":"Zaccaria, G. M. et al. A clinical prognostic model based on machine learning from the Fondazione Italiana linfomi (FIL) MCL0208 phase III trial. Cancers (Basel) 14 (1), 188 (2021).","journal-title":"Cancers (Basel)"},{"issue":"4","key":"18148_CR10","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.1097\/HS9.0000000000000706","volume":"6","author":"A Mosquera Orgueira","year":"2022","unstructured":"Mosquera Orgueira, A. et al. Prognostic stratification of diffuse large B-cell lymphoma using Clinico-genomic models: validation and improvement of the LymForest-25 model. Hemasphere 6 (4), e706 (2022).","journal-title":"Hemasphere"},{"issue":"26","key":"18148_CR11","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1056\/NEJMc1906060","volume":"380","author":"B Van Calster","year":"2019","unstructured":"Van Calster, B. & Wynants, L. Machine learning in medicine. N Engl. J. Med. 380 (26), 2588 (2019).","journal-title":"N Engl. J. Med."},{"key":"18148_CR12","doi-asserted-by":"publisher","first-page":"1435284","DOI":"10.3389\/fphar.2024.1435284","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Predicting the efficiency of Chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm. Front. Pharmacol. 15, 1435284 (2024).","journal-title":"Front. Pharmacol."},{"issue":"14","key":"18148_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl. J. Med. 329 (14), 987\u2013994 (1993).","journal-title":"N Engl. J. Med."},{"issue":"7","key":"18148_CR14","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini, A. et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103 (7), 2474\u20132479 (2004).","journal-title":"Blood"},{"issue":"11","key":"18148_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.V106.11.811.811","volume":"106","author":"JM Vose","year":"2005","unstructured":"Vose, J. M. & Project, T. I. P. International peripheral T-Cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood 106 (11), 811\u2013811 (2005).","journal-title":"Blood"},{"issue":"2","key":"18148_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico, M. et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J. Clin. Oncol. 31 (2), 240\u2013246 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"18148_CR17","doi-asserted-by":"publisher","first-page":"300060521101327","DOI":"10.1177\/03000605211013274","volume":"49","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. A novel prognostic model for angioimmunoblastic T-cell lymphoma: A retrospective study of 55 cases. J. Int. Med. Res. 49 (5), 3000605211013274 (2021).","journal-title":"J. Int. Med. Res."},{"key":"18148_CR18","doi-asserted-by":"publisher","first-page":"153303382096423","DOI":"10.1177\/1533033820964231","volume":"19","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Development of a novel clinical prognostic model for patients with angioimmunoblastic T-Cell lymphoma. Technol. Cancer Res. Treat. 19, 1533033820964231 (2020).","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"18148_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/1097-0142(19870115)59:2<208::AID-CNCR2820590205>3.0.CO;2-7","volume":"59","author":"E Archimbaud","year":"1987","unstructured":"Archimbaud, E. et al. Prognostic factors in angioimmunoblastic lymphadenopathy. Cancer 59 (2), 208\u2013212 (1987).","journal-title":"Cancer"},{"issue":"8331","key":"18148_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(83)92129-3","volume":"1","author":"E Archimbaud","year":"1983","unstructured":"Archimbaud, E. et al. Rash implies poor prognosis in angioimmunoblastic lymphadenopathy. Lancet 1 (8331), 998\u2013999 (1983).","journal-title":"Lancet"},{"issue":"1","key":"18148_CR21","doi-asserted-by":"publisher","first-page":"12907","DOI":"10.1038\/s41598-018-31212-z","volume":"8","author":"Y Shang","year":"2018","unstructured":"Shang, Y. et al. B2 microglobulin is a novel prognostic marker of angioimmunoblastic T-cell lymphoma. Sci. Rep. 8 (1), 12907 (2018).","journal-title":"Sci. Rep."},{"issue":"12","key":"18148_CR22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3109\/10428190903318311","volume":"50","author":"D Chihara","year":"2009","unstructured":"Chihara, D. et al. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy. Leuk. Lymphoma. 50 (12), 1999\u20132004 (2009).","journal-title":"Leuk. Lymphoma"},{"key":"18148_CR23","doi-asserted-by":"crossref","unstructured":"McDermott, M. B. A. et al. Reproducibility in machine learning for health research: Still a ways to go. Sci Transl Med, 13(586). (2021).","DOI":"10.1126\/scitranslmed.abb1655"},{"issue":"10","key":"18148_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/CM9.0000000000003090","volume":"137","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications. Chin. Med. J. (Engl) 137 (10), 1151\u20131159 (2024).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"2","key":"18148_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","volume":"33","author":"JR Cortes","year":"2018","unstructured":"Cortes, J. R. et al. RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis. Cancer Cell. 33 (2), 259\u2013273 (2018). .e7.","journal-title":"Cancer Cell."},{"issue":"10","key":"18148_CR26","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba, S. & Sakata-Yanagimoto, M. Advances in Understanding of angioimmunoblastic T-cell lymphoma. Leukemia 34 (10), 2592\u20132606 (2020).","journal-title":"Leukemia"},{"issue":"1","key":"18148_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41375-021-01321-2","volume":"36","author":"JC Pritchett","year":"2022","unstructured":"Pritchett, J. C. et al. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia 36 (1), 165\u2013176 (2022).","journal-title":"Leukemia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18148-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:13:26Z","timestamp":1760361206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18148-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18148"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18148-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Fujian Medical University Union Hospital, the Ethics Committee of West China Hospital of Sichuan University, the Ethics Committee of Sichuan Cancer Hospital, and the Ethics Committee of Sichuan Provincial People\u2019s Hospital. All the patients included in the study signed the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}}],"article-number":"35606"}}